HOME > Investors > Press Releases
2018-07-05
Drug based on ViroMed’s VM202 Technology Successfully Completes Phase II for CLI in China
2018-07-02
2018.06(IR letter) BusinessUpdates
2018-05-30
ViroMed Announces Publication of VM202’s MoA in Nerve Regeneration
2018-05-23
VM BioPharma Presents at Pain Therapeutics Conference in UK
2018-05-18
Reyon’s Lawsuit Dismissed by Court
1 2 3 4 5 6 7 8 9 10